Macular Degeneration Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Macular Degeneration stocks.

Macular Degeneration Stocks Recent News

Date Stock Title
May 17 OTLK Q2 2024 Outlook Therapeutics Inc Earnings Call
May 17 EYPT Insider Sale: Director David Guyer Sells Shares of EyePoint Pharmaceuticals Inc (EYPT)
May 16 OTLK Outlook Therapeutics, Inc. (OTLK) Q2 2024 Earnings Call Transcript
May 16 KOD Kodiak (KOD) Q1 Loss Narrower Than Expected, Pipeline in Focus
May 15 OTLK Outlook Therapeutics reports Q2 results
May 15 KOD Kodiak Sciences GAAP EPS of -$0.82 beats by $0.21
May 15 OTLK Outlook Therapeutics® Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update
May 15 KOD Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results
May 15 RGNX Evaluating Regenxbio: Insights From 9 Financial Analysts
May 15 TCON Q1 2024 TRACON Pharmaceuticals Inc Earnings Call
May 15 TCON TRACON Pharmaceuticals Inc (TCON) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 15 ALIM Alimera Sciences Inc (ALIM) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...
May 15 TCON TRACON Pharmaceuticals, Inc. (TCON) Q1 2024 Earnings Call Transcript
May 14 KALA Kala Pharmaceuticals GAAP EPS of -$4.20
May 14 KALA KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 14 TCON Tracon GAAP EPS of -$1.33 misses by $0.15, revenue of $0.1M
May 14 TCON TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 14 ALIM Alimera Sciences, Inc. (ALIM) Q1 2024 Earnings Call Transcript
May 14 ALIM Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates
May 14 APLS Apellis Pharmaceuticals enters into senior secured credit facility
Macular Degeneration

Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.Macular degeneration typically occurs in older people. Genetic factors and smoking also play a role. It is due to damage to the macula of the retina. Diagnosis is by a complete eye exam. The severity is divided into early, intermediate, and late types. The late type is additionally divided into "dry" and "wet" forms with the dry form making up 90% of cases.Preventive efforts include exercising, eating well, and not smoking. Antioxidant vitamins and minerals do not appear to be useful for prevention. There is no cure or treatment that returns vision already lost. In the wet form, anti-VEGF medication injected into the eye or less commonly laser coagulation or photodynamic therapy may slow worsening. Supplements in those who already have the disease may slow progression.In 2015 it affected 6.2 million people globally. In 2013 it was the fourth most common cause of blindness after cataracts, preterm birth, and glaucoma. It most commonly occurs in people over the age of fifty and in the United States is the most common cause of vision loss in this age group. About 0.4% of people between 50 and 60 have the disease, while it occurs in 0.7% of people 60 to 70, 2.3% of those 70 to 80, and nearly 12% of people over 80 years old.

Browse All Tags